{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T18:35:40Z","timestamp":1768674940484,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,16]]},"DOI":"10.7759\/cureus.101715","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T07:35:22Z","timestamp":1768635322000},"source":"Crossref","is-referenced-by-count":0,"title":["Expanding the Clinical Spectrum of VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome: The First Report of Histologically Confirmed Neutrophilic Colitis With Rare Muscular and Pancreatic Involvement"],"prefix":"10.7759","author":[{"given":"Sarah","family":"El Tahech","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussein","family":"Nassereddine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Moukheiber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georges","family":"Maalouly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-023-03193-z","article-title":"VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases","volume":"18","author":"Vitale A","year":"2023","unstructured":"Vitale A, Caggiano V, Bimonte A, et al.. VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases. Intern Emerg Med. 2023, 18:711-22. 10.1007\/s11739-023-03193-z","journal-title":"Intern Emerg Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20805","article-title":"Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients","volume":"186","author":"Georgin-Lavialle S","year":"2022","unstructured":"Georgin-Lavialle S, Terrier B, Guedon AF, et al.. Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients. Br J Dermatol. 2022, 186:564-74. 10.1111\/bjd.20805","journal-title":"Br J Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck DB","year":"2020","unstructured":"Beck DB, Ferrada MA, Sikora KA, et al.. Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N Engl J Med. 2020, 383:2628-38. 10.1056\/NEJMoa2026834","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004976","article-title":"Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1","volume":"5","author":"Obiorah IE","year":"2021","unstructured":"Obiorah IE, Patel BA, Groarke EM, et al.. Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1. Blood Adv. 2021, 5:3203-15. 10.1182\/bloodadvances.2021004976","journal-title":"Blood Adv"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.3344","article-title":"UBA1 variations in neutrophilic dermatosis skin lesions of patients with VEXAS syndrome","volume":"157","author":"Zakine E","year":"2021","unstructured":"Zakine E, Schell B, Battistella M, et al.. UBA1 variations in neutrophilic dermatosis skin lesions of patients with VEXAS syndrome. JAMA Dermatol. 2021, 157:1349-54. 10.1001\/jamadermatol.2021.3344","journal-title":"JAMA Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.10.052","article-title":"Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: a multicenter retrospective study of 59 cases","volume":"88","author":"Zakine \u00c8","year":"2023","unstructured":"Zakine \u00c8, Papageorgiou L, Bourguiba R, et al.. Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: a multicenter retrospective study of 59 cases. J Am Acad Dermatol. 2023, 88:917-20. 10.1016\/j.jaad.2022.10.052","journal-title":"J Am Acad Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/art.43287","article-title":"American College of Rheumatology guidance statement for diagnosis and management of VEXAS developed by the International VEXAS Working Group Expert Panel","volume":"4","author":"Mekinian AM","year":"2025","unstructured":"Mekinian AM, Georgin-Lavaille S, Ferrada MA, et al.. American College of Rheumatology guidance statement for diagnosis and management of VEXAS developed by the International VEXAS Working Group Expert Panel. Arthritis Rheumatol. 2025, 4:26-8. 10.1002\/art.43287","journal-title":"Arthritis Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-024-03014-3","article-title":"Ocular and orbital manifestations in VEXAS syndrome","volume":"38","author":"Abumanhal M","year":"2024","unstructured":"Abumanhal M, Leibovitch I, Zisapel M, Eviatar T, Edel Y, Ben Cnaan R. Ocular and orbital manifestations in VEXAS syndrome. Eye (Lond). 2024, 38:1748-54. 10.1038\/s41433-024-03014-3","journal-title":"Eye (Lond)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae135","article-title":"Trismus as a new feature of VEXAS syndrome","volume":"63","author":"Archambeaud A","year":"2024","unstructured":"Archambeaud A, Le Dreau C, Bigot A, et al.. Trismus as a new feature of VEXAS syndrome. Rheumatology (Oxford). 2024, 63:e258-60. 10.1093\/rheumatology\/keae135","journal-title":"Rheumatology (Oxford)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-024-03763-9","article-title":"The role of (18)FDG-PET imaging in VEXAS syndrome: a multicentric case series and a systematic review of the literature","volume":"19","author":"Bixio R","year":"2024","unstructured":"Bixio R, Bindoli S, Morciano A, et al.. The role of (18)FDG-PET imaging in VEXAS syndrome: a multicentric case series and a systematic review of the literature. Intern Emerg Med. 2024, 19:2331-45. 10.1007\/s11739-024-03763-9","journal-title":"Intern Emerg Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.05.014","article-title":"Adult-onset autoinflammation caused by somatic mutations in UBA1: a\u00a0Dutch case series of patients with VEXAS","volume":"149","author":"van der Made CI","year":"2022","unstructured":"van der Made CI, Potjewijd J, Hoogstins A, et al.. Adult-onset autoinflammation caused by somatic mutations in UBA1: a\u00a0Dutch case series of patients with VEXAS. J Allergy Clin Immunol. 2022, 149:432-9. 10.1016\/j.jaci.2021.05.014","journal-title":"J Allergy Clin Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.1016 Abstract","article-title":"VEXAS without vacuoles: linking genotype to phenotype","volume":"5","author":"Zhukovsky S","year":"2024","unstructured":"Zhukovsky S, Rets A, Braaten T, Patel AB. VEXAS without vacuoles: linking genotype to phenotype. EJHaem. 2024, 5:981-6. 10.1002\/jha2.1016 Abstract","journal-title":"EJHaem"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1770958","article-title":"VEXAS syndrome-review","volume":"10","author":"Zhang Y","year":"2023","unstructured":"Zhang Y, Dong X, Wang H. VEXAS syndrome-review. Glob Med Genet. 2023, 10:133-43. 10.1055\/s-0043-1770958","journal-title":"Glob Med Genet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0016-5085(00)70183-1","article-title":"AGA technical review on intestinal ischemia. American Gastrointestinal Association","volume":"118","author":"Brandt LJ","year":"2000","unstructured":"Brandt LJ, Boley SJ. AGA technical review on intestinal ischemia. American Gastrointestinal Association. Gastroenterology. 2000, 118:954-68. 10.1016\/s0016-5085(00)70183-1","journal-title":"Gastroenterology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.983939","article-title":"Vasculitis associated with VEXAS syndrome: a literature review","volume":"9","author":"Watanabe R","year":"2022","unstructured":"Watanabe R, Kiji M, Hashimoto M. Vasculitis associated with VEXAS syndrome: a literature review. Front Med (Lausanne). 2022, 9:983939. 10.3389\/fmed.2022.983939","journal-title":"Front Med (Lausanne)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae550","article-title":"Vasculitis associated with VEXAS syndrome","volume":"64","author":"Sullivan MM","year":"2025","unstructured":"Sullivan MM, Mead-Harvey C, Sartori-Valinotti JC, et al.. Vasculitis associated with VEXAS syndrome. Rheumatology (Oxford). 2025, 64:3889-94. 10.1093\/rheumatology\/keae550","journal-title":"Rheumatology (Oxford)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/art.42257","article-title":"Clinical images: VEXAS syndrome presenting as treatment-refractory polyarteritis nodosa","volume":"74","author":"Itagane M","year":"2022","unstructured":"Itagane M, Teruya H, Kato T, et al.. Clinical images: VEXAS syndrome presenting as treatment-refractory polyarteritis nodosa. Arthritis Rheumatol. 2022, 74:1863-4. 10.1002\/art.42257","journal-title":"Arthritis Rheumatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4045\/tidsskr.21.0370","article-title":"A man in his sixties with chondritis and bone marrow failure","volume":"142","author":"Midtvedt \u00d8","year":"2022","unstructured":"Midtvedt \u00d8, Stray-Pedersen A, Andersson H, Gunnarsson R, Tveten K, Ali MM, Tj\u00f8nnfjord GE. A man in his sixties with chondritis and bone marrow failure. Tidsskr Nor Laegeforen. 2022, 142:32-4. 10.4045\/tidsskr.21.0370","journal-title":"Tidsskr Nor Laegeforen"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab866","article-title":"Successful treatment with azacitidine in VEXAS syndrome with prominent myofasciitis","volume":"61","author":"Cordts I","year":"2022","unstructured":"Cordts I, Hecker JS, Gauck D, et al.. Successful treatment with azacitidine in VEXAS syndrome with prominent myofasciitis. Rheumatology (Oxford). 2022, 61:e117-9. 10.1093\/rheumatology\/keab866","journal-title":"Rheumatology (Oxford)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac356","article-title":"Novel genetic mutation in myositis-variant of VEXAS syndrome","volume":"61","author":"Topilow JS","year":"2022","unstructured":"Topilow JS, Ospina Cardona D, Beck DB, Ferrada MA, McMahan ZH, Paik JJ. Novel genetic mutation in myositis-variant of VEXAS syndrome. Rheumatology (Oxford). 2022, 61:e371-3. 10.1093\/rheumatology\/keac356","journal-title":"Rheumatology (Oxford)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/425809-expanding-the-clinical-spectrum-of-vexas-vacuoles-e1-enzyme-x-linked-autoinflammatory-somatic-syndrome-the-first-report-of-histologically-confirmed-neutrophilic-colitis-with-rare-muscular-and-pancreatic-involvement","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T07:35:22Z","timestamp":1768635322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/425809-expanding-the-clinical-spectrum-of-vexas-vacuoles-e1-enzyme-x-linked-autoinflammatory-somatic-syndrome-the-first-report-of-histologically-confirmed-neutrophilic-colitis-with-rare-muscular-and-pancreatic-involvement"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.101715","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,16]]}}}